Efficacy of a Self-advocacy Serious Game Intervention
Launched by UNIVERSITY OF PITTSBURGH · Mar 20, 2021
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to help women with advanced cancer improve their quality of life by teaching them self-advocacy skills through a serious game. The game, called Strong Together, allows participants to step into the shoes of characters facing similar challenges. By making decisions for these characters about how to advocate for their own care, players can see the positive and negative outcomes of their choices. The goal is to empower women with cancer to better manage their symptoms and concerns, leading to more patient-centered care.
To be eligible for this trial, participants must be women aged 18 or older who have been diagnosed with advanced solid organ cancer within the last six months and are receiving treatment that is not intended to cure the cancer. They should expect to engage in interactive sessions using the game, where they will set personal goals and learn valuable skills they can apply in real life. It’s important to note that this study is only for women who are not currently on hospice care and do not have any severe cognitive or mental health issues.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female
- • ≥18 years
- • Diagnosed with advanced solid organ cancer within the past 6 months being treated with non-curative intent
- • Have at least a 6-month life expectancy (as determined by their oncologist)
- • Eastern Cooperative Oncology Group performance score of 0 to 2 (per health record or oncologist)
- • Able to read and write in English
- Exclusion Criteria:
- • On hospice at the time of recruitment
- • Impaired cognition (per health record)
- • Other active, unstable mental health disorder
About University Of Pittsburgh
The University of Pittsburgh is a leading research institution known for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a robust infrastructure for research and a multidisciplinary approach, the university fosters collaboration among experts in various fields, facilitating the development of novel therapies and interventions. Its clinical trial programs emphasize ethical standards, patient safety, and the integration of cutting-edge technology, making the University of Pittsburgh a pivotal contributor to the landscape of clinical research and a trusted partner in the pursuit of health advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pittsburgh, Pennsylvania, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials